Company: SXTPW
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043779
Chunk: 28

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 28
---
 a summary of the
activity for the Company’s equity-classified warrants during the three months ended March 31, 2025:

     Number of Warrants   Weighted Average Exercise Price   Weighted Average Remaining Contractual Life (Years)   Total outstanding, December 31, 2024(1)   1,765,070   $17.59    3.26   Granted   747,200    3.56    2.00   Exercised   (385,200)   0.01    Indefinite   Forfeited   -    -    -   Expired   -    -    -   Total outstanding, March 31, 2025   2,127,070   $15.85    2.60   Total exercisable, March 31, 2025   2,127,070   $15.85    2.60 

(1)Weighted average remaining contractual life at December 31,
2024 excludes 385,200 Pre-Funded Warrants issued September 2024 that do not have a contractual expiration date, for which 0 warrants
remain outstanding and exercisable at March 31, 2025.

During the three months ended March 31, 2025,
the Company received aggregate cash proceeds of $1,926 upon the exercise of 385,200 pre-funded warrants issued in September 2024.

The following table presents a summary of the
activity for the Company’s equity-classified warrants during the three months ended March 31, 2024:

     Number of Warrants   Weighted Average Exercise Price   Weighted Average Remaining Contractual Life (Years)   Total outstanding, December 31, 2023   52,737   $369.98    4.47   Granted   140,884    22.48    5.00   Exercised   (8,326)   0.60    Indefinite   Forfeited   -    -    -   Expired   -    -    -   Total outstanding, March 31, 2024   185,295   $